This inventor holds 1 USPTO granted patent. Top assignee: Xenova Limited. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: David James Hardick: Innovator in Cytokine Production and Tyrosine Kinase Inhibitors
Introduction
David James Hardick is a notable inventor based in Slough, GB. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that inhibit cytokine production and tyrosine kinase activity. His work is crucial for advancing treatments for immunoinflammatory and cancerous conditions.
Latest Patents
David James Hardick holds a patent for a compound that has the potential to inhibit cytokine production and tyrosine kinase. The patent describes a compound of formula (I), which includes various structural components that allow for its activity as an inhibitor. The detailed chemical formulations and processes for producing these compounds from fungal strains are also outlined in his patent.
Career Highlights
Hardick is associated with Xenova Limited, where he has been instrumental in research and development. His innovative work has led to advancements in therapeutic applications, particularly in the treatment of diseases related to immune response and cancer.
Collaborations
Some of his notable coworkers include Steven Michael Martin and Roya Mansour Sadeghi Guilani. Their collaborative efforts have contributed to the success of various projects within the company.
Conclusion
David James Hardick's contributions to the field of biotechnology through his patent and work at Xenova Limited highlight his role as an important inventor. His research continues to pave the way for new therapeutic strategies in treating complex medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile